All In Biotech

Drug Trial Radar · NCT00474032

Using Botox to Treat Patients With Idiopathic Clubfoot

Efficacy of Botox in Patients With Idiopathic Clubfoot

Last checked: Nov 20, 2026Latest source record: May 18, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

2,000

Planned (sponsor's estimate)

Start

Mar 2003

Primary completion

Mar 2023

Study completion Mar 2023

Sponsor

Lead sponsor
University of British ColumbiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 16, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the effectiveness of treatment of idiopathic clubfoot utilizing Botulinum Toxin Type A (Botox). This is not a hypothesis-generating study as we are reporting on outcomes of patients who have been treated by this method of clubfoot treatment.

Conditions

  • Clubfoot

Interventions

  • Botulinum Toxin (Type A) injection (10 U/Kg)Drug

    See Detailed Description.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Surgery rate at any point

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • BC Children's Hospital

    Vancouver, British Columbia, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.